Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 1/2012

01-01-2012 | Article

Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines

Authors: H.-S. Moon, J. P. Chamberland, C. S. Mantzoros

Published in: Diabetologia | Issue 1/2012

Login to get access

Abstract

Aims/hypothesis

It has been suggested that amylin amplifies leptin’s effects and affects energy homeostasis synergistically with leptin in animals and humans. However, no previous study has reported on amylin and leptin signalling in hypothalamic, muscle and liver cells.

Methods

Leptin and amylin signalling studies were performed in vitro in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines.

Results

Treatment of mouse GT1-7 and C2C12 cells with leptin or amylin increased signal transducer and activator of transcription 3 (STAT3) phosphorylation in a dose- and time-dependent manner. In mouse AML12 cells, leptin and amylin produced a biphasic response of STAT3 activity. Importantly, all leptin and amylin signalling pathways were saturable at leptin and amylin concentrations of ∼100 and ∼50 to 100 ng/ml, respectively. Leptin and amylin in combination activated STAT3, AMP-activated protein kinase (AMPK), extracellular signal-regulated kinase (ERK) 1/2 and Akt signalling pathways in an additive manner, effects that were abolished under endoplasmic reticulum (ER) stress. Leptin, but not amylin, increased IRS-1 phosphorylation in GT1-7 hypothalamic, but not in C2C12 muscle and AML12 liver cell lines.

Conclusions/interpretation

Our data suggest that leptin and amylin have overlapping and additive, but not synergistic, effects in the activation of intracellular signalling pathways. ER stress may induce leptin and amylin resistance in hypothalamic, muscle and liver cell lines. These novel insights into the mode of action of leptin and amylin suggest that these hormones may play an additive role in regulating energy homeostasis in humans.
Appendix
Available only for authorised users
Literature
1.
Badman MK, Flier JS (2005) The gut and energy balance: visceral allies in the obesity wars. Science 307:1909–1914PubMedCrossRef
2.
Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS (2010) Leptin in human physiology and therapeutics. Front Neuroendocrinol 31:377–393PubMedCrossRef
3.
Fiorenza CG, Chou SH, Mantzoros CS (2011) Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol 7:137–150PubMedCrossRef
4.
Moon HS, Matarese G, Brennan AM et al (2011) Efficacy of metreleptin in obese type II diabetics: cellular and molecular pathways underlying leptin tolerance. Diabetes 60:1647–1656PubMedCrossRef
5.
Moon HS, Chamberland JP, Diakopoulos KN et al (2010) Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues; in vitro and ex vivo studies in humans. Diabetes Care 34:132–138PubMedCrossRef
6.
Matarese G, Moschos S, Mantzoros CS (2005) Leptin in immunology. J Immunol 174:3137–3142PubMed
7.
Pelleymounter MA, Cullen MJ, Baker MB et al (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540–543PubMedCrossRef
8.
Kim YB, Uotani S, Pierroz DD, Flier JS, Kahn BB (2000) In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141:2328–2339PubMedCrossRef
9.
Roth JD, Maier H, Chen S, Roland BL (2009) Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications. Arch Neurol 66:306–310PubMedCrossRef
10.
Ravussin E, Smith SR, Mitchell JA et al (2009) Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring) 17:1736–1743CrossRef
11.
Roth JD, Roland BL, Cole RL et al (2008) Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 105:7257–7262PubMedCrossRef
12.
Trevaskis JL, Coffey T, Cole R et al (2008) Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. Endocrinology 149:5679–5687PubMedCrossRef
13.
Hwang JJ, Chan JL, Ntali G, Malkova D, Mantzoros CS (2008) Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide— Interventional studies in humans. Diabetes Care 31:945–951PubMedCrossRef
14.
Ozcan L, Ergin AS, Lu A et al (2009) Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 9:35–51PubMedCrossRef
15.
Hagiwara S, Iwasaka H, Shingu C et al (2009) Heat shock protein 72 protects insulin-secreting beta cells from lipopolysaccharide-induced endoplasmic reticulum stress. Int J Hyperthermia 25:626–633PubMedCrossRef
16.
Moon HS, Chung CS, Lee HG, Kim TG, Choi YJ, Cho CS (2007) Inhibitory effect of (–)-epigallocatechin-3-gallate on lipid accumulation of 3 T3-L1 cells. Obesity (Silver Spring) 15:2571–2582CrossRef
17.
Maroni P, Bendinelli P, Piccoletti R (2005) Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell Biol Int 29:542–550PubMedCrossRef
18.
Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661–671PubMed
19.
Ahima RS, Saper CB, Flier JS, Elmquist JK (2000) Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21:263–307PubMedCrossRef
20.
Bates SH, Myers MG (2003) The role of leptin receptor signalling in feeding and neuroendocrine function. Trends Endocrinol Metab 14:447–452PubMedCrossRef
21.
Turek VF, Trevaskis JL, Levin BE et al (2010) Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 151:143–152PubMedCrossRef
22.
Hardie DG, Carling D, Carlson M (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821–855PubMedCrossRef
23.
Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA (1999) Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 24:22–25PubMedCrossRef
24.
Holmes BF, Kurth-Kraczek EJ, Winder WW (1999) Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87:1990–1995PubMed
25.
Bjorbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305–331PubMedCrossRef
26.
Suzuki A, Okamoto S, Lee S, Saito K, Shiuchi T, Minokoshi Y (2007) Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol 27:4317–4327PubMedCrossRef
27.
Rahmouni K, Sigmund CD, Haynes WG, Mark AL (2009) Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 58:536–542PubMedCrossRef
28.
Huang XF, Chen JZ (2009) Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev 10:610–616PubMedCrossRef
29.
Lang T, Ikejima K, Yoshikawa M et al (2004) Leptin facilitates proliferation of hepatic stellate cells through up-regulation of platelet-derived growth factor receptor. Biochem Biophys Res Commun 323:1091–1095PubMedCrossRef
30.
Misztal-Dethloff B, Stepien H, Komorowski J (2004) Effect of leptin on proliferative activity and vascular endothelial growth factor (VEGF) secretion from cultured endothelial cells HECa10 in vitro. Endocr Regul 38:161–166PubMed
31.
Cohen B, Novick D, Rubinstein M (1996) Modulation of insulin activities by leptin. Science 274:1185–1188PubMedCrossRef
32.
Mosthaf L, Kellerer M, Mühlhöfer A, Mushack J, Seffer E, Häring HU (1996) Insulin leads to a parallel translocation of PI-3-kinase and protein kinase C zeta. Exp Clin Endocrinol Diabetes 104:19–24PubMedCrossRef
33.
Niswender KD, Morton GJ, Steams WH, Rhodes CJ, Myers MG Jr, Schwartz MW (2001) Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413:794–795PubMedCrossRef
34.
Anisimov SV, Christophersen NS, Correia AS et al (2010) Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells. Cell Mol Biol Lett 16:79–88PubMedCrossRef
35.
Magariños MP, Sánchez-Margalet V, Kotler M, Calvo JC, Varone CL (2007) Leptin promotes cell proliferation and survival of trophoblastic cells. Biol Reprod 76:203–210PubMedCrossRef
36.
Jiang L, Li Z, Rui L (2008) Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways. J Biol Chem 283:28066–28073PubMedCrossRef
37.
Cornish J, Callon KE, Bava U et al (2006) Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo. Am J Physiol Endocrinol Metab 292:E117–E122PubMedCrossRef
38.
39.
Chan JL, Mantzoros CS (2005) Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 366:74–85PubMedCrossRef
40.
Lee JH, Chan JL, Sourlas E, Raptopoulos V, Mantzoros CS (2006) Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. J Clin Endocrinol Metab 91:2605–2611PubMedCrossRef
41.
Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152:93–100PubMed
42.
Ziemke F, Mantzoros CS (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91:258S–261SPubMedCrossRef
Metadata
Title
Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines
Authors
H.-S. Moon
J. P. Chamberland
C. S. Mantzoros
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 1/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2332-0

Other articles of this Issue 1/2012

Diabetologia 1/2012 Go to the issue

Erratum

Erratum to: Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E

Article

Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice

Article

Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individuals

Article

Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients

Article

Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men

Article

Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits